Pre-transplant use of tyrosine kinase inhibitors and transplant associated thrombotic microangiopathy - a single centre analysis of incidence, risk factors and outcomes-Reference-Cited by-同舟云学术

Pre-transplant use of tyrosine kinase inhibitors and transplant associated thrombotic microangiopathy - a single centre analysis of incidence, risk factors and outcomes

Published:2021-01-29 Issue:7 Volume:56 Page:1558-1562
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Punatar Sachin^ORCID,Kalantri Siddhesh A.^ORCID,Chichra Akanksha,Agrawal Amit Kumar,Nayak Lingaraj,Bonda Avinash,Gokarn Anant,Bagal Bhausaheb^ORCID,Mathew Libin,Kannan Sadhana,Khattry Navin^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-021-01213-0.pdf

Reference13 articles.

1. Khosla J, Yeh AC, Spitzer TR, Dey BR. Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies. Bone Marrow Transpl. 2018;53:129–37. https://doi.org/10.1038/bmt.2017.207.

2. Laskin BL, Goebel J, Davies SM, Jodele S. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood. 2011;118:1452–62. https://doi.org/10.1182/blood-2011-02-321315.

3. Uderzo C, Bonanomi S, Busca A, Renoldi M, Ferrari P, Iacobelli M, et al. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Transplantation. 2006;82:638–44.

4. Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M, et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2005;11:571–5.

5. Ruutu T, Barosi G, Benjamin RJ, Clark RE, George JN, Gratwohl A, et al. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica. 2007;92:95–100.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for transplant-associated thrombotic microangiopathy (TA-TMA): a systematic review and meta-analysis;Expert Review of Hematology;2023-01-02

2. Clinical Study of Transplant-Associated Thrombotic Microangiopathy;Advances in Clinical Medicine;2022

3. Sorafenib;Reactions Weekly;2021-09